Gynecologic Cancer

Technology-enabled symptom monitoring in conjunction with nurse practitioner follow-up provided responsive care to patients with cancer during the COVID-19 pandemic, according to study results.

Women with ovarian cancer appeared to be at greater risk for anxiety, depression and adjustment disorder within the first 2 years of diagnosis than women in the general population, study results showed.

The FDA cleared an investigational new drug application for the combination of AFM24 and SNK-01 in patients with solid tumors that express epidermal growth factor receptor, according to a joint press release from each agent’s manufacturer.

Postoperative systemic or radiation therapy did not extend survival for women with high-risk stage I endometrial cancer, according to results presented at the virtual Society of Gynecologic Oncology Annual Meeting on Women’s Cancer.

The addition of paclitaxel to cisplatin in a hyperthermic intraperitoneal chemotherapy regimen doubled PFS among women with advanced epithelial ovarian cancer undergoing interval debulking surgery, study results showed.

Interventions designed to improve care for Black women with endometrial cancer can help overcome clinical trial inequities, according to findings presented at the virtual Society of Gynecologic Oncology Annual Meeting on Women’s Cancer.

Rucaparib significantly prolonged PFS compared with chemotherapy for women with BRCA-mutated advanced, relapsed ovarian cancer, according to a study presented at the virtual Society of Gynecologic Oncology Annual Meeting on Women’s Cancer.

Treatment with a levonorgestrel-dispensing intrauterine device appeared to be effective and safe for women with stage I endometrial adenocarcinoma or endometrial hyperplasia with atypia, according to results of a randomized, phase 2 study.

Most female gynecologic oncologists who responded to an internet-based survey reported having experienced workplace bullying, according to a presentation at the virtual Society of Gynecologic Oncology Annual Meeting on Women’s Cancer.

Regionalization of care for high-grade endometrial cancer in Ontario had no negative effect on surgical wait times, according to findings presented at the virtual Society of Gynecologic Oncology Annual Meeting on Women’s Cancer.